𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Everolimus for the treatment of pancreatic neuroendocrine tumors

✍ Scribed by Feldmann, Georg; Bisht, Savita; Schütte, Ute; Haarmann, Jens; Brossart, Peter

Book ID
118057743
Publisher
Informa plc
Year
2012
Tongue
English
Weight
319 KB
Volume
13
Category
Article
ISSN
1465-6566

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Everolimus for Advanced Pancreatic Neuro
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
✍ Yao, James C.; Shah, Manisha H.; Ito, Tetsuhide; Bohas, Catherine Lombard; Wolin 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 667 KB

## Background: Everolimus, an oral inhibitor of mammalian target of rapamycin (mtor), has shown antitumor activity in patients with advanced pancreatic neuroendocrine tumors, in two phase 2 studies. we evaluated the agent in a prospective, randomized, phase 3 study. ## Methods: We randomly assign